 Patients will be screened for eligibility to determine if they meet all inclusionexclusion criteria. The screening period will be up to 4 weeks. Patients baseline LIC will be determined non-invasively by means of MRI R2 analysis. In addition, blood and urine samples will be taken for the determination of baseline safety data. 